According to our new research study on “Organoids Market to 2027 – Global Analysis and Forecast – by Type, Application, and Source,” the organoids market was valued at US$ 689.47… Read More
PENTICTON, British Columbia & SAN DIEGO − May 10, 2021 (Newswire.com) – XCO Tech Inc. and Atlazo, Inc. have announced the formation of Recon Health Inc., a joint venture to commercialize… Read More
Early identification of unique cell markers is expected to have valuable impact on patents, clinical efficacy, and manufacturing optimization VANCOUVER, BC – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)… Read More
VANCOUVER, BC, May 11, 2021 /PRNewswire/ — Bold Therapeutics, a clinical-stage biopharmaceutical company, is announcing that the U.S. Food & Drug Administration (FDA) has granted BOLD-100 an Orphan Drug Designation (ODD)… Read More
Vancouver, BC – May 6, 2021 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ:INM; TSX:IN), a clinical-stage company developing pharmaceutical-based drug candidates and leading the way in the clinical… Read More
